News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
590,413 Results
Type
Article (42531)
Company Profile (320)
Press Release (547562)
Section
Business (167327)
Career Advice (2438)
Deals (30275)
Drug Delivery (102)
Drug Development (78580)
Employer Resources (149)
FDA (14359)
Job Trends (12976)
News (295465)
Policy (28465)
Tag
Academia (2652)
Alliances (42793)
Alzheimer's disease (1353)
Approvals (14311)
Artificial intelligence (180)
Bankruptcy (318)
Best Places to Work (10678)
Biotechnology (258)
Breast cancer (209)
Cancer (1577)
Cardiovascular disease (134)
Career advice (2046)
CAR-T (116)
Cell therapy (334)
Clinical research (62874)
Collaboration (587)
Compensation (232)
COVID-19 (2534)
C-suite (148)
Data (1498)
Diabetes (192)
Diagnostics (5674)
Earnings (60402)
Employer resources (137)
Events (88131)
Executive appointments (519)
FDA (15132)
Funding (533)
Gene therapy (242)
GLP-1 (660)
Government (4190)
Healthcare (17209)
Infectious disease (2630)
Inflammatory bowel disease (124)
Interviews (520)
IPO (14164)
Job creations (2736)
Job search strategy (1680)
Layoffs (418)
Legal (6016)
Lung cancer (240)
Manufacturing (203)
Medical device (11016)
Medtech (11020)
Mergers & acquisitions (16384)
Metabolic disorders (525)
Neuroscience (1758)
NextGen: Class of 2025 (5968)
Non-profit (4111)
Northern California (1761)
Obesity (293)
Opinion (216)
Patents (135)
People (53418)
Phase I (19729)
Phase II (27779)
Phase III (20678)
Pipeline (624)
Postmarket research (2389)
Preclinical (8314)
Radiopharmaceuticals (250)
Rare diseases (314)
Real estate (4471)
Regulatory (19858)
Research institute (2265)
Resumes & cover letters (360)
Southern California (1592)
Startups (3161)
United States (15693)
Vaccines (559)
Weight loss (214)
Date
Today (121)
Last 7 days (581)
Last 30 days (2269)
Last 365 days (33162)
2025 (2194)
2024 (33528)
2023 (37471)
2022 (48408)
2021 (52018)
2020 (49980)
2019 (42541)
2018 (32084)
2017 (29605)
2016 (28150)
2015 (32900)
2014 (25341)
2013 (20525)
2012 (21738)
2011 (22667)
2010 (20372)
Location
Africa (737)
Arizona (147)
Asia (35952)
Australia (7151)
California (4094)
Canada (1501)
China (351)
Colorado (180)
Connecticut (180)
Europe (80506)
Florida (575)
Georgia (134)
Illinois (381)
Indiana (218)
Maryland (668)
Massachusetts (3066)
Michigan (176)
Minnesota (277)
New Jersey (1156)
New York (1163)
North Carolina (752)
Northern California (1761)
Ohio (137)
Pennsylvania (893)
South America (1015)
Southern California (1592)
Texas (576)
Utah (123)
Washington State (402)
590,413 Results for "tarveda therapeutics fomerly known as blend therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Immunology and inflammation
Gilead Continues Diversification Drive With Potential $1.7B Inflammation Pact With LEO
Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 and IL-13 signaling, which in turn are known inflammatory targets.
January 13, 2025
·
2 min read
·
Tristan Manalac
Pharm Country
Perseus Therapeutics Announces Development of TSLP Antibody for Prevention of Hair Loss in Cancer Patients and Treatment of Inflammatory Diseases with well-known CRO partner
Perseus Therapeutics, a pioneering biopharmaceutical company based in New York City, is proud to announce the development of a novel thymic stromal lymphopoietin (TSLP) antibody aimed at preventing hair loss in cancer patients and treating a range of inflammatory diseases, including asthma.
May 22, 2024
·
2 min read
Press Releases
Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
December 24, 2024
·
4 min read
Press Releases
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 13, 2025
·
9 min read
Business
Ascidian Therapeutics Enters Collaboration with Roche for Discovery and Development of RNA Exon Editing Therapeutics Targeting Neurological Diseases
Ascidian Therapeutics today announced a research collaboration and licensing agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) for the discovery and development of RNA exon editing therapeutics targeting neurological diseases.
June 18, 2024
·
3 min read
Press Releases
Silver Bullet Therapeutics Announces FDA Approval of Pre-Market Study
January 16, 2025
·
4 min read
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Asthma Therapeutics Market Size to Reach USD 22.0 Billion by 2032, Impelled by Favorable Government Initiatives
Asthma Therapeutics Market Outlook 2024-2032:
August 8, 2024
·
10 min read
1 of 59,042
Next
